RIEMSER
is a pharmaceutical company that distributes drugs for oncology, cardiovascular, obesity and dermatology disorders... Read moreRIEMSER
is a pharmaceutical company that distributes drugs for oncology, cardiovascular, obesity and dermatology disorders... Read more
CEO
Konstantin von Alvensleben
News
Jan 09, 2020
in-PharmaTechnologist
RIEMSER: One in, one out: Esteve pivots to specialty products
Jan 09, 2020
Business Medical Dialogues
RIEMSER: Esteve to buy German pharma firm Riemser from Ardian
Jan 08, 2020
FiercePharma
RIEMSER: Spain's Esteve sells a plant then buys one as it refocuses on specialty drugs
Oct 03, 2019
Unquote
Riemser Pharma: Ardian-backed Riemser buys Zaltan | Unquote
Oct 02, 2018
BioPortfolio
Riemser Pharma: Riemser Pharma GmbH Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 24072018 Prices from USD $250
Aug 02, 2018
BioPortfolio
Riemser Pharma: Riemser Pharma GmbH Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 14062018 Prices from USD $250
Mar 30, 2018
BioPortfolio
Riemser Pharma: Riemser Pharma GmbH Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 14032018 Prices from USD $250
Sep 02, 2017
BioPortfolio
Riemser Pharma: Riemser Pharma GmbH Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 24082017 Prices from USD $250
Jun 01, 2017
BioPortfolio
Riemser Pharma: Riemser Pharma GmbH Pharmaceuticals Healthcare Deals and Alliances Profile Updated 12052017 Prices from USD $250
Mar 22, 2017
BioPortfolio
Riemser Pharma: Riemser Pharma GmbH Pharmaceuticals Healthcare Deals and Alliances Profile Updated 21022017 Prices from USD $250
